Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$24.6M |
| 2 |
Paycom
PAYC
|
+$13.6M |
| 3 |
Veeva Systems
VEEV
|
+$11M |
| 4 |
NVIDIA
NVDA
|
+$2.69M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$19.8M |
| 2 |
HDFC Bank
HDB
|
+$13.2M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$10.3M |
| 4 |
PayPal
PYPL
|
+$9.75M |
| 5 |
Microsoft
MSFT
|
+$9.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.51% |
| 2 | Healthcare | 17.03% |
| 3 | Consumer Discretionary | 10.46% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 7.25% |
Similar funds
Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Loring Wolcott & Coolidge Fiduciary Advisors held 595 positions worth $10.1B, down 0.32% from $10.1B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Loring Wolcott & Coolidge Fiduciary Advisors's Q1 2024 filing shows 41 new, 67 increased, 176 reduced and 32 closed positions. Its largest new stake was GE Vernova: 3,494 shares worth $478K. The largest sale was Mastercard, an estimated $19.8M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Loring Wolcott & Coolidge Fiduciary Advisors's largest Q1 2024 buy was GE Vernova: 3,494 shares worth $478K.
- Loring Wolcott & Coolidge Fiduciary Advisors added most to Regeneron Pharmaceuticals in Q1 2024, an estimated $24.6M increase.
- Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q1 2024 reduction was Mastercard, cutting an estimated $19.8M.
- Loring Wolcott & Coolidge Fiduciary Advisors fully exited Wheaton Precious Metals in Q1 2024, selling an estimated $497K.
- Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 46% of its $10.1B portfolio in Q1 2024.
- Loring Wolcott & Coolidge Fiduciary Advisors opened 41 new positions and closed 32 in Q1 2024.
- Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value fell 0.32% quarter-over-quarter to $10.1B.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q1 2024, filed 23 Apr 2024.